Shares of USANA Health Sciences, Inc. (NYSE:USNA) were getting banged up, falling 10% after peer Nu Skin Enterprises plummeted 26% on an investigation into its practices by the Chinese government. USANA Health Sciences, Inc. (NYSE:USNA) stock opened at $59.00 in last session, and closed at $59.56, while the day range of stock is $58.50 – $59.97. The stock showed a negative weekly performance of -17.17%.
Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of purchasers of Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR) securities during the period between March 15, 2012 and January 9, 2014, inclusive (the “Class Period”). Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) stock opened at $59.82, in last session and closed at $62.51, by gaining 4.20%. The 52 week range of the stock is $25.92 – $101.00. Company’s market capitalization is $1.83 billion.
Considering that Mannkind Corporation (NASDAQ:MNKD) jumped almost 18 percent on Thursday last week and closed the week at 16.38 percent in red ink suggest that investors are trading the stock with an eye on its clinical candidate Afrezza. MannKind Corporation (NASDAQ:MNKD) stock decreased -3.74% and finished the last session at $5.79. The EPS of the stock remained -0.71. Company’s market capitalization is $2.07 billion.
Corcept Therapeutics Incorporated (NASDAQ:CORT) was downgraded by stock analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating in a report issued on Monday, TheFlyOnTheWall.com reports. Corcept Therapeutics Incorporated (NASDAQ:CORT) stock opened the session at $3.28, and closed the session at $3.19. The 52 week range of the stock remained $1.47 – $3.83 and the day range was $3.14 – $3.29.